Matches in SemOpenAlex for { <https://semopenalex.org/work/W2965211518> ?p ?o ?g. }
- W2965211518 abstract "Heterotopic ossification (HO) refers to the appearance of osteoblasts in soft tissues under pathological conditions, such as trauma or infection. HO arises in an unpredictable way without any recognizable initiation. Activin receptor‑like kinase‑2 (ALK2) is a type I cell surface receptor for bone morphogenetic proteins (BMPs). The dysregulation of ALK2 signaling is associated with a variety of diseases, including cancer and HO. At present, the prevention and treatment of HO in the clinic predominantly includes nonsteroidal anti‑inflammatory drugs (NSAIDs), bisphosphonates and other drug treatments, low‑dose local radiation therapy and surgical resection, rehabilitation treatment and physical therapy. However, most of these therapies have adverse effects. These methods do not prevent the occurrence of HO. The pathogenesis of HO is not being specifically targeted; the current treatment strategies target the symptoms, not the disease. These treatments also cannot solve the fundamental problem of the occurrence of HO. Therefore, scholars have been working to develop targeted therapies based on the pathogenesis of HO. The present review focuses on advances in the understanding of the underlying mechanisms of HO, and possible options for the prevention and treatment of HO. In addition, the role of ALK2 in the process of HO is introduced and the progress made towards the targeted inhibition of ALK2 is discussed. The present study aims to offer a platform for further research on possible targets for the prevention and treatment of HO." @default.
- W2965211518 created "2019-08-13" @default.
- W2965211518 creator A5010983049 @default.
- W2965211518 creator A5012188851 @default.
- W2965211518 creator A5018801130 @default.
- W2965211518 creator A5052173587 @default.
- W2965211518 creator A5072913469 @default.
- W2965211518 date "2019-08-06" @default.
- W2965211518 modified "2023-09-30" @default.
- W2965211518 title "Targeting heterotopic ossification by inhibiting activin receptor‑like kinase 2 function (Review)" @default.
- W2965211518 cites W1569358330 @default.
- W2965211518 cites W1826012123 @default.
- W2965211518 cites W1924653416 @default.
- W2965211518 cites W1965528910 @default.
- W2965211518 cites W1976084770 @default.
- W2965211518 cites W1976808417 @default.
- W2965211518 cites W1977504067 @default.
- W2965211518 cites W1990905351 @default.
- W2965211518 cites W1992948990 @default.
- W2965211518 cites W1993174948 @default.
- W2965211518 cites W1993861234 @default.
- W2965211518 cites W1993959445 @default.
- W2965211518 cites W1999855562 @default.
- W2965211518 cites W2001094206 @default.
- W2965211518 cites W2005915052 @default.
- W2965211518 cites W2012836529 @default.
- W2965211518 cites W2017594888 @default.
- W2965211518 cites W2018862827 @default.
- W2965211518 cites W2019777614 @default.
- W2965211518 cites W2033134304 @default.
- W2965211518 cites W2037159434 @default.
- W2965211518 cites W2039115684 @default.
- W2965211518 cites W2040121303 @default.
- W2965211518 cites W2040203747 @default.
- W2965211518 cites W2041814673 @default.
- W2965211518 cites W2046752665 @default.
- W2965211518 cites W2047642636 @default.
- W2965211518 cites W2059460453 @default.
- W2965211518 cites W2062055610 @default.
- W2965211518 cites W2066050937 @default.
- W2965211518 cites W2074230216 @default.
- W2965211518 cites W2077324135 @default.
- W2965211518 cites W2078369164 @default.
- W2965211518 cites W2079932277 @default.
- W2965211518 cites W2080929272 @default.
- W2965211518 cites W2082152178 @default.
- W2965211518 cites W2084637690 @default.
- W2965211518 cites W2089870628 @default.
- W2965211518 cites W2101217309 @default.
- W2965211518 cites W2102912402 @default.
- W2965211518 cites W2109792507 @default.
- W2965211518 cites W2113679184 @default.
- W2965211518 cites W2120389451 @default.
- W2965211518 cites W2122540501 @default.
- W2965211518 cites W2123126591 @default.
- W2965211518 cites W2124460804 @default.
- W2965211518 cites W2124680336 @default.
- W2965211518 cites W2127716291 @default.
- W2965211518 cites W2145162845 @default.
- W2965211518 cites W2145304853 @default.
- W2965211518 cites W2150908534 @default.
- W2965211518 cites W2155008946 @default.
- W2965211518 cites W2158859553 @default.
- W2965211518 cites W2158913105 @default.
- W2965211518 cites W2170806255 @default.
- W2965211518 cites W2171133614 @default.
- W2965211518 cites W2187451625 @default.
- W2965211518 cites W2187578403 @default.
- W2965211518 cites W2189567545 @default.
- W2965211518 cites W2205033369 @default.
- W2965211518 cites W227158685 @default.
- W2965211518 cites W2293273525 @default.
- W2965211518 cites W2333668994 @default.
- W2965211518 cites W2341793557 @default.
- W2965211518 cites W2343938601 @default.
- W2965211518 cites W2390730892 @default.
- W2965211518 cites W2402101036 @default.
- W2965211518 cites W2498942019 @default.
- W2965211518 cites W2523329823 @default.
- W2965211518 cites W2552044784 @default.
- W2965211518 cites W2589104060 @default.
- W2965211518 cites W2597236224 @default.
- W2965211518 cites W2605187236 @default.
- W2965211518 cites W2609113069 @default.
- W2965211518 cites W2743394875 @default.
- W2965211518 cites W2749037511 @default.
- W2965211518 cites W2752198650 @default.
- W2965211518 cites W2754093171 @default.
- W2965211518 cites W2770441210 @default.
- W2965211518 cites W2786308339 @default.
- W2965211518 cites W2789279500 @default.
- W2965211518 cites W2789533197 @default.
- W2965211518 cites W2790340587 @default.
- W2965211518 cites W2792012337 @default.
- W2965211518 cites W2799666811 @default.
- W2965211518 cites W2804600409 @default.
- W2965211518 cites W2889177969 @default.
- W2965211518 cites W2898978951 @default.
- W2965211518 cites W2955980570 @default.
- W2965211518 cites W4244095134 @default.